Neuroimmune disorders – including CIDP, Multiple Sclerosis, NMO, and Guillain-Barré Syndrome (GBS), MOGAD – demand sophisticated understanding of disease progression, treatment complexity, symptom management, and patient outcomes across diverse care settings. As the therapeutic landscape expands with novel immunomodulatory agents, advanced biologic therapies, and emerging targeted interventions, obtaining high-quality real-world evidence is critical to support clinical strategies, inform healthcare decisions, and demonstrate clinical and quality-of-life value to key stakeholders.
Adelphi Real World’s Disease Specific Programmes (DSPs) are purpose-built to address these challenges.
Our Neuroimmune DSPs provide comprehensive, actionable real-world data and insights tailored to the distinctive features of autoimmune neurological disease progression and symptom management. By engaging directly with neuroimmune specialists, neurologists, immunologists, patients, and caregivers, our DSPs deliver granular perspectives on:
Treatment Sequencing & Management Patterns
Understand real-world therapy selection, combination strategies, and sequential treatment approaches across neuroimmune disorder types, disease stages, patient demographics, and healthcare systems – capturing adoption of emerging therapies and treatment decision pathways in routine neuroimmune practice.
Physician Decision-Making
Explore the clinical reasoning behind treatment choices, factors influencing therapy selection in early versus advanced disease, symptom management strategies, relapse prevention approaches, and strategies for disease monitoring and functional assessment.
Patient & Caregiver Experiences & Outcomes
Document real-world efficacy, tolerability profiles, symptom control, functional preservation, relapse frequency, quality of life, caregiver burden, support needs, and lived experiences in everyday clinical settings – revealing gaps between trial data and real-world patient and family experience across neuroimmune disorder populations.
Emerging Unmet Needs
Uncover persistent treatment challenges, gaps in disease management, emerging therapeutic opportunities, disease progression prevention strategies, treatment side effect management, medication adherence barriers, caregiver support gaps, and opportunities for therapeutic innovation to better serve patients with neuroimmune disorders.
Neuroimmune Disease Specific Programmes (DSP) Portfolio
Why Partner With Adelphi Real World for Neuroimmune Disorder Research?
Extensive Global Coverage
Our DSP network spans multiple countries, providing robust comparative insights into neuroimmune practice, treatment adoption, diagnostic approaches, and healthcare delivery across diverse healthcare systems.
Deep Clinical Expertise
With specialised knowledge of neuroimmune disorders, we ensure our data collection, analysis, and interpretation reflect the true complexity of autoimmune neurological disease management and the needs of treating clinicians and supporting caregivers.
Evidence That Drives Impact
From clinical development to reimbursement and healthcare provider engagement, our neuroimmune DSPs provide the credible, compelling evidence needed to influence decisions across the healthcare ecosystem.
Neuroimmune Disorder DSP Coverage
Who We Work With
We partner strategically with biopharmaceutical innovators, neurology practices, neuroimmunology specialist centres, hospital networks, immunology facilities, rehabilitation centres, patient support organisations, caregiver advocacy groups, and healthcare policymakers to generate evidence that transforms neuroimmune disorder care globally.
Let’s Get Started
- Schedule a Consultation: Meet with our neuroimmune specialists to discuss how our DSPs can support your research, development, and market access objectives across CIDP, Multiple Sclerosis, NMO, GBS and MOGAD.
- Get More Details: Want to explore our methodology, disease focus areas, global reach, caregiver insights, or specialist networks? We’re here to answer your questions and provide customised information.
Adelphi Real World brings together real-world expertise, neuroimmune disorder insight, and global reach to help you succeed in neuroimmune research. Let’s collaborate to advance evidence and improve outcomes for patients with neuroimmune disorders.
Contact us today using the form below.
Conferences Attending
Observational Research